The Novartis Board of Directors proposes a dividend payment of CHF 3.70 per share for 2025, up 5.7% from CHF 3.50 per share in the prior year, representing the 29th consecutive dividend increase since ...

April 26, 2023 Today Novartis has published updated 2022 quarterly and full year segment financials reflecting transfers of Sandoz biotechnology manufacturing services to other companies’ activities ...

MSL-CSU Regulär, Full time Development China Guangzhou (Guangdong Province) Feb 02, 2026 ...

(高级）医药代表 /（资深）产品专员 Regular (Sales), Full time Sales China Yancheng (Jiangsu Province) Feb 01, 2026 ...

Novartis is building and inspired, curious and unbossed culture. The history of Novartis started in the middle of the 18th century. Novartis, as we know it today, was founded in 1996 by the merger of ...

Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III trials to demonstrate statistically significant reduction in disease activity for Sjögren’s ...

To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.

Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the company's business operations. ECN members are chosen by the Board of Directors.

Novartis is committed to improving the accessibility and usability of our websites, ensuring that content and services are available to all visitors, regardless of their ability or the technology they ...

Novartis agrees to take actions aimed at meeting US Administration priorities for drug pricing Additional Novartis medicines will be made available through direct-to-patient platforms in 2026 Company ...

V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...

Ανακαλύπτουμε και αναπτύσσουμε πρωτοποριακές θεραπείες και βρίσκουμε νέους τρόπους για να τις παραδώσουμε σε όσο το δυνατόν περισσότερους ανθρώπους. Η Novartis συνεργάζεται με την κοινότητα ...